CRISPR THERAPEUTICS AG (CRSP) Debt Components
- 2026-06-30: Long-term DebtUSD $586.20M; Long-term Debt, GrossUSD $600.00M; Debt Instrument, Interest Rate, Effective Percentagepure 0.50%; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD $13.80M.
- 2026-03-31: Long-term DebtUSD $585.47M; Long-term Debt, GrossUSD $600.00M; Debt Instrument, Interest Rate, Effective Percentagepure 0.50%; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD $14.53M.
- 2025-12-31: Long-term DebtUSD $0.00; Long-term Debt, GrossUSD $0.00; Debt Instrument, Interest Rate, Effective Percentagepure (m); Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD $0.00.
- 2025-06-30: Long-term DebtUSD (m); Long-term Debt, GrossUSD (m); Debt Instrument, Interest Rate, Effective Percentagepure 0.00%; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD (m).
CRISPR THERAPEUTICS AG Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt USD | Long-term Debt, Gross USD | Debt Instrument, Interest Rate, Effective Percentage pure | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD |
|---|---|---|---|---|
| 2026-06-30 | $586.20M | $600.00M | 0.50% | $13.80M |
| 2026-03-31 | $585.47M | $600.00M | 0.50% | $14.53M |
| 2025-12-31 | $0.00 | $0.00 | (m) | $0.00 |
| 2025-06-30 | (m) | (m) | 0.00% | (m) |
| 2025-03-31 | (m) | (m) | 0.00% | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |